Want to see BIOA full AI Analyst Report?
ETFs with BioAge Labs, Inc. (BIOA) Exposure
The following ETFs maintain exposure to BioAge Labs, Inc. (BIOA). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
50 ETFs Hold BioAge Labs, Inc. (BIOA)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in BIOA |
|---|---|---|---|---|---|---|
| XPH | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | 0.58% | $2.63M | 0.97% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.25% | $86.95K | 0.03% |
| VMO | Vanguard GlbMomntFac | $490.96M | 0.44% | 0.13% | $676.10K | 0.04% |
| BUSM | EA Bridgeway Ultra-Small Company Market ETF | $115.26M | 0.73% | 0.09% | $98.35K | 0.04% |
| IHE | iShares U.S. Pharmaceuticals ETF | $1.60B | 0.37% | 0.05% | $772.67K | 0.29% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.05% | $571.71K | 0.21% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | 0.03% | $335.51K | 0.12% |
| FESM | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | 0.02% | $1.26M | 0.46% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.02% | $21.12K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.02% | $220.20K | 0.08% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.01% | $189.56K | 0.06% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.01% | $1.45M | 0.54% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | 0.01% | $1.57M | 0.58% |
| AVSC | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | 0.01% | $355.06K | 0.13% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | <0.01% | $368.61K | 0.14% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | <0.01% | $1.32M | 0.40% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | <0.01% | $1,006.78 | <0.01% |
| DFMC | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | <0.01% | $580.35K | 0.14% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | <0.01% | $20.26K | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | <0.01% | $4.85M | 1.78% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | <0.01% | $92.09K | 0.03% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | <0.01% | $10.76K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $65.34 | <0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | <0.01% | $1.21M | 0.44% |
| PRFZ | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | <0.01% | $141.04K | 0.05% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $1.37M | 0.50% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $3.15M | 0.97% |
| WDSC | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | <0.01% | $55.24K | 0.02% |
| WSCD | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | <0.01% | $55.24K | 0.02% |
| MSML | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | <0.01% | $7,870.5 | <0.01% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | <0.01% | $94.08K | 0.03% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | <0.01% | $26.49K | <0.01% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | <0.01% | $192.86K | 0.07% |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | $1.82B | 0.09% | <0.01% | $21.38K | <0.01% |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | <0.01% | $7,888.32 | <0.01% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $231.66 | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $12.12K | <0.01% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $374.61K | 0.14% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $8.09M | 2.49% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $19.67K | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $272.82K | 0.10% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $54.30K | 0.02% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $95.68K | 0.04% |
| DCOR | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | <0.01% | $66.22K | 0.02% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | <0.01% | $1,235.52 | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $1,235.52 | <0.01% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $689.81 | <0.01% |
| AVTM | Avantis Total Equity Markets ETF | $779.89M | 0.22% | <0.01% | $712.8 | <0.01% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $11.64K | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $23.76 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in BIOA |
|---|---|---|---|---|---|---|
| XPH | 0.58% | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | $2.63M | 0.97% |
| BBC | 0.25% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $86.95K | 0.03% |
| VMO | 0.13% | Vanguard GlbMomntFac | $490.96M | 0.44% | $676.10K | 0.04% |
| BUSM | 0.09% | EA Bridgeway Ultra-Small Company Market ETF | $115.26M | 0.73% | $98.35K | 0.04% |
| IHE | 0.05% | iShares U.S. Pharmaceuticals ETF | $1.60B | 0.37% | $772.67K | 0.29% |
| IWC | 0.05% | iShares Micro-Cap ETF | $1.26B | 0.60% | $571.71K | 0.21% |
| GSSC | 0.03% | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | $335.51K | 0.12% |
| FESM | 0.02% | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | $1.26M | 0.46% |
| IBBQ | 0.02% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $21.12K | <0.01% |
| OM3E | 0.02% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $220.20K | 0.08% |
| VTWV | 0.01% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $189.56K | 0.06% |
| IBB | 0.01% | iShares Biotechnology ETF | $11.52B | 0.44% | $1.45M | 0.54% |
| IWN | 0.01% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $1.57M | 0.58% |
| AVSC | 0.01% | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | $355.06K | 0.13% |
| R2EH | <0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $368.61K | 0.14% |
| VTWO | <0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $1.32M | 0.40% |
| VRSD | <0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $1,006.78 | <0.01% |
| DFMC | <0.01% | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | $580.35K | 0.14% |
| RTYS | <0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $20.26K | <0.01% |
| IWM | <0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $4.85M | 1.78% |
| RSSL | <0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $92.09K | 0.03% |
| ITWO | <0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $10.76K | <0.01% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $65.34 | <0.01% |
| SCHA | <0.01% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $1.21M | 0.44% |
| PRFZ | <0.01% | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | $141.04K | 0.05% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $1.37M | 0.50% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $3.15M | 0.97% |
| WDSC | <0.01% | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | $55.24K | 0.02% |
| WSCD | <0.01% | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | $55.24K | 0.02% |
| MSML | <0.01% | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | $7,870.5 | <0.01% |
| FHLC | <0.01% | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | $94.08K | 0.03% |
| VTWG | <0.01% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $26.49K | <0.01% |
| IWO | <0.01% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $192.86K | 0.07% |
| SPGM | <0.01% | SPDR Portfolio MSCI Global Stock Market ETF | $1.82B | 0.09% | $21.38K | <0.01% |
| MSSM | <0.01% | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | $7,888.32 | <0.01% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $231.66 | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $12.12K | <0.01% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $374.61K | 0.14% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $8.09M | 2.49% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $19.67K | <0.01% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $272.82K | 0.10% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $54.30K | 0.02% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $95.68K | 0.04% |
| DCOR | <0.01% | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | $66.22K | 0.02% |
| AVGC | <0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $1,235.52 | <0.01% |
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $1,235.52 | <0.01% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $689.81 | <0.01% |
| AVTM | <0.01% | Avantis Total Equity Markets ETF | $779.89M | 0.22% | $712.8 | <0.01% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $11.64K | <0.01% |
| DDUM | <0.01% | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | $23.76 | <0.01% |
Popular ETF Comparisons
BIOA ETF Exposure FAQ
What ETFs hold BioAge Labs, Inc. stock?
BioAge Labs, Inc. (BIOA) is currently held by 50 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to BIOA include SPDR (XPH), Fidelity (FESM) and iShares (IHE).
Which ETF has the largest exposure to BIOA?
The ETF with the largest exposure to BIOA is SPDR (XPH), with approximately $2.63M in market value exposure.
How much BIOA stock is held by ETFs?
ETFs currently hold approximately $6.67M worth of BioAge Labs, Inc. (BIOA) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.